Abecma

idecabtagene vicleucel · Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Abecma, covering 2024-12-13 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma [Phase 2]